Christopher Bunka, CEO, 10% Owner at Lexaria Bioscience Corp. (LXRP), bought 5,100 shares at $0.13 ($663) on 2016-08-26, disclosed to the SEC on 2016-08-29.
Seasonal purchase ($663) by CEO, 10% Owner — this insider has traded LXRP in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| LXRP | BUY | 2016-10-11 | $3K | — | Filing → |
| LXRP | BUY | 2016-10-06 | $375 | — | Filing → |
| LXRP | BUY | 2016-08-25 | $3K | — | Filing → |